Events Archives - Page 251 of 287

TuesdayJun 06, 2017 8:30 pm

SenesTech, Inc. (NASDAQ: SNES) Starts Presentation at LD Micro 2017 Invitational

SenesTech, Inc. (NASDAQ: SNES) is the developer of an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The company's first fertility control product, ContraPest®, is marketed for use initially in controlling rat infestations. ContraPest is designed, formulated and dispensed to be safe for handlers and non-target species such as wildlife, livestock and pets, in a biodegradable product. In contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental contamination and the poisoning of non-target animals, pets and children. For more information, visit the company’s website at www.senestech.com.…

TuesdayJun 06, 2017 8:30 pm

US Nuclear Corp. (UCLE) Starts Presentation at LD Micro 2017 Invitational

US Nuclear (OTCBB: UCLE), through its subsidiaries, is engaged in operating two nuclear radiation detection companies: Overhoff Technology Corp. and Optron Scientific Company, Inc. US Nuclear designs, manufactures and markets branded, full-line radiation detection and specialized advanced tritium technology for the nuclear energy industry, as well as for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies for domestic and international customers including U.S. Government Agencies, the U.S. Military, homeland security, scientific laboratories, universities, hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others. For more information, visit the company’s website at…

TuesdayJun 06, 2017 8:00 pm

Atomera, Inc. (NASDAQ: ATOM) Starts Presentation at LD Micro 2017 Invitational

Atomera (NASDAQ: ATOM) is a development-stage company that focuses on developing, commercializing and licensing proprietary processes and technologies for the semiconductor industry. It develops Mears Silicon Technology, or MST, a thin film of reengineered silicon that can be applied as a transistor channel enhancement to CMOS-type transistors in the semiconductor industry. The company was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016. Atomera was founded in 2001 and is headquartered in Los Gatos, California. For more information, visit the company's website at www.atomera.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

TuesdayJun 06, 2017 8:00 pm

Synacor, Inc. (NASDAQ: SYNC) Starts Presentation at LD Micro 2017 Invitational

Synacor, Inc. (NASDAQ: SYNC) delivers modern, multiscreen experiences and advertising to their consumers that require scale, actionable data and sophisticated implementation. Reaching 120 million monthly visitors, 120 service providers, 3500 enterprises, 500 million email boxes and more than 1000 web publishers, Synacor’s suite of multiscreen products and platforms and its advertising inventory provide a targeted means of extending its customers’ brands and boosting their revenues. Synacor is headquartered in Buffalo, with offices in Boston, Dallas, London, New York, Ottawa, Pune, San Francisco, Singapore, Tokyo and Toronto. For more information, visit the company’s website at www.synacor.com About NetworkNewsWire NetworkNewsWire (NNW) is an information…

TuesdayJun 06, 2017 7:30 pm

Misonix, Inc. (NASDAQ: MSON) Starts Presentation at LD Micro 2017 Invitational

Misonix (NASDAQ: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices in the United States and internationally. The company provides medical devices that are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies including BoneScalpel, SonaStar, and SonicOne. For more information, visit the company’s website at www.misonix.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3) a full…

TuesdayJun 06, 2017 7:30 pm

GrowGeneration Corp. (GRWG) Starts Presentation at LD Micro 2017 Invitational

GrowGeneration (OTCQB: GRWG) is one of the largest operators of specialty retail hydroponic and organic gardening stores, offering products for both commercial and home cannabis growers. The company currently has 13 locations, including nine in Colorado, two in California, one in Nevada and one in Washington. Among the thousands of products GrowGen carries and sells, the company offers organic nutrients and soils, advanced lighting technology and cutting-edge hydroponic equipment for indoor and outdoor use. The company’s mission is to own and operate GrowGeneration branded stores in all major legalized cannabis states. For more information, visit the company’s website at www.growgeneration.com.…

TuesdayJun 06, 2017 7:30 pm

AmpliPhi Biosciences Corp. (NYSE: APHB) Starts Presentation at LD Micro 2017 Invitational

AmpliPhi Biosciences (NYSE: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. AmpliPhi's product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi has reported final results from two phase 1 clinical trials of AB-SA01, one for the treatment of Staphylococcus aureus (S. aureus) in chronic rhinosinusitis patients and one to evaluate the safety of AB-SA01 when administered topically to the intact skin of healthy adults. AmpliPhi is also developing bacteriophage therapeutics targeting Pseudomonas aeruginosa (P. aeruginosa) and Clostridium difficile (C. difficile) in collaboration with a number of leading…

TuesdayJun 06, 2017 7:30 pm

LM Funding America, Inc. (NASDAQ: LMFA) Starts Presentation at LD Micro 2017 Invitational

LM Funding America (NASDAQ: LMFA) operates as a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida, as well as in the states of Washington, Colorado and Illinois. The company offers funding to associations by purchasing their rights under delinquent accounts that are selected by the associations arising from unpaid association assessments. It is also involved in the business of purchasing delinquent accounts on various terms tailored to suit each association's financial needs, including under its New Neighbor Guaranty program. For more information, visit the company's website at www.lmfunding.com. About NetworkNewsWire NetworkNewsWire…

TuesdayJun 06, 2017 7:00 pm

CopSync, Inc. (NASDAQ: COYN) Starts Presentation at LD Micro 2017 Invitational

CopSync (NASDAQ: COYN) operates a real-time law enforcement mobile data information system in the United States. The company provides COPsync Network, a software as a service, which enables patrol officers to collect, report and share critical data in real-time at the point of incident and obtain instant access to various local, state and federal law enforcement databases. The company’s COPsync Network service also enables officers to electronically write tickets; process DUI and other arrests; document accidents and other incidents; as well as allows dispatchers and officers to send be on the lookout and other alerts of child kidnappings, robberies, car…

TuesdayJun 06, 2017 7:00 pm

Gemphire Therapeutics, Inc. (NASDAQ: GEMP) Starts Presentation at LD Micro 2017 Invitational

Gemphire Therapeutics (NASDAQ: GEMP) is a clinical-stage biopharmaceutical company engaged in developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and NASH. The company’s focus is on providing new treatment options for cardiometabolic diseases through gemcabene, its complementary, convenient and cost-effective product candidate, as an add-on to the standard of care—particularly statins that will benefit patients, physicians and payors. The company has initiated three clinical trials for homozygous familial hypercholesterolemia (HoFH), heterozygous familial hypercholesterolemia (HeFH)/atherosclerotic cardiovascular disease (ASCVD), and severe hypertriglyceridemia (SHTG). A fourth trial is planned to be initiated in NASH during the second half of 2017. For more…